Pancreatic Cancer Research

ResearcherMigra-Therapeutics, LlcActive in the last 2 years

Lily Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2959-0094; OpenAlex author ID A5041917469; NIH RePORTER profile ID 6736718. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 4)
Trials
0
Grants
9
Labs led
1
Collaborators
24
Papers, trials and grants by year

2013: 1 paper · 2014: 1 grant · 2015: 1 paper, 1 grant · 2016: 1 paper · 2017: 3 papers · 2018: none · 2019: 1 paper, 2 grants · 2020: 1 grant · 2021: none · 2022: 1 paper · 2023: 1 grant · 2024: 1 paper · 2025: 1 grant · 2026: 2 grants

Papers 9

  1. Muc16CD is a novel CAR T cell target antigen for the treatment of pancreatic cancer. Co-author DOI 10.1016/j.omton.2024.200868↗
  2. Advanced iron oxide nanotheranostics for multimodal and precision treatment of pancreatic ductal adenocarcinoma. Last author DOI 10.1002/wnan.1793↗
  3. Significance of IL28RA in diagnosis of early pancreatic cancer and its regulation to pancreatic cancer cells by JAK/STAT signaling pathway - effects of IL28RA … Co-author DOI 10.26355/eurrev_201911_19550↗
  4. Inhibiting heat shock protein 90 and the ubiquitin-proteasome pathway impairs metabolic homeostasis and leads to cell death in human pancreatic cancer cells. Co-author DOI 10.1002/cncr.30944↗
  5. Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy. Last author DOI 10.1016/j.canlet.2016.11.030↗
  6. Targeted Molecular Imaging of Pancreatic Cancer with a Miniature Endoscope. Co-author DOI 10.3390/app7121241↗
  7. Functionalized milk-protein-coated magnetic nanoparticles for MRI-monitored targeted therapy of pancreatic cancer. Co-author DOI 10.2147/ijn.s92722↗
  8. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer. Last author DOI 10.1021/acsnano.5b01288↗
  9. Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer. Last author DOI 10.1021/nn3043463↗

Grants 9

  1. Biomimetic Migrating Nanoparticles Targeting Tumor Stroma and Neural Invasion to Improve Pancreatic Cancer Therapy and Pain Control R01CA315249↗
  2. Development of tumor targeting and stroma penetrating toxin for pancreatic cancer treatment R43CA310425↗
  3. Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer R01CA261251↗
  4. Translational Development of a Targeted and Stroma-penetrating Nanoparticle Drug for Pancreatic Cancer Therapy R44CA246827↗
  5. Tumor Stroma Breaking System for Efficient Delivery of Therapeutic Agents R41CA247165↗
  6. Translational Development of a Targeted and Stroma-breaking Nanoparticle Drug for Pancreatic Cancer Therapy R43CA246827↗
  7. Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy U01CA198913↗
  8. MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer R01CA154846↗
  9. Theranostic Nano particles for Targeted Treatment of Pancreatic Cancer U01CA151810↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hui Mao · 5 shared papers, 4 shared grants, 2013–2025 · strength 2.35
  2. Lei Zhu · 3 shared grants, 2019–2026 · strength 2.28
  3. lingxun Duan · 1 shared grant, 2023 · strength 0.61
  4. Lei Zhu · 1 shared grant, 2020 · strength 0.38
  5. H Trent Spencer · 1 shared grant, 2020 · strength 0.38
  6. Lei Zhu · 2 shared papers, 2017–2022 · strength 0.34
  7. Gregory B. Lesinski · 2 shared papers, 2017–2024 · strength 0.31
  8. Heather K. Lin · 1 shared paper, 2024 · strength 0.24
  9. Sarwish Rafiq · 1 shared paper, 2024 · strength 0.24
  10. David A. Kooby · 2 shared papers, 2015–2017 · strength 0.13
  11. W-W Zeng · 1 shared paper, 2019 · strength 0.11
  12. Jun Gao · 1 shared paper, 2019 · strength 0.11
  13. Xianjin Dai · 1 shared paper, 2017 · strength 0.09
  14. Huabei Jiang · 1 shared paper, 2017 · strength 0.09
  15. Astrid Belalcazar · 1 shared paper, 2017 · strength 0.07
  16. Matthew R. Farren · 1 shared paper, 2017 · strength 0.07
  17. Walid Labib Shaib · 1 shared paper, 2017 · strength 0.07
  18. Ganji Purnachandra Nagaraju · 1 shared paper, 2017 · strength 0.07
  19. Bassel F. El‐Rayes · 1 shared paper, 2017 · strength 0.07
  20. Hongbo Chen · 1 shared paper, 2016 · strength 0.06
  21. Jing Huang · 1 shared paper, 2016 · strength 0.06
  22. Hongyu Zhou · 1 shared paper, 2015 · strength 0.05
  23. Liya Wang · 1 shared paper, 2015 · strength 0.05
  24. Gee Young Lee · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.